Vaccinex's market value is the price at which a share of Vaccinex trades on a public exchange. It measures the collective expectations of Vaccinex investors about its performance. Vaccinex is trading at 1.25 as of the 17th of February 2026; that is 16.11 percent decrease since the beginning of the trading day. The stock's open price was 1.49. With this module, you can estimate the performance of a buy and hold strategy of Vaccinex and determine expected loss or profit from investing in Vaccinex over a given investment horizon. Check out Vaccinex Correlation, Vaccinex Volatility and Vaccinex Performance module to complement your research on Vaccinex.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vaccinex's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Vaccinex 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaccinex's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaccinex.
0.00
11/19/2025
No Change 0.00
0.0
In 2 months and 31 days
02/17/2026
0.00
If you would invest 0.00 in Vaccinex on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Vaccinex or generate 0.0% return on investment in Vaccinex over 90 days. Vaccinex is related to or competes with Medigene, Chia Tai, and Biomind Labs. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through... More
Vaccinex Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaccinex's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaccinex upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaccinex's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaccinex's standard deviation. In reality, there are many statistical measures that can use Vaccinex historical prices to predict the future Vaccinex's volatility.
Vaccinex is out of control given 3 months investment horizon. Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.6% are justified by taking the suggested risk. Use Vaccinex Coefficient Of Variation of 497.84, semi deviation of 7.45, and Risk Adjusted Performance of 0.1714 to evaluate company specific risk that cannot be diversified away. Vaccinex holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of 2.21, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vaccinex will likely underperform. Use Vaccinex sortino ratio, as well as the relationship between the semi variance and rate of daily change , to analyze future returns on Vaccinex.
Auto-correlation
0.26
Poor predictability
Vaccinex has poor predictability. Overlapping area represents the amount of predictability between Vaccinex time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaccinex price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Vaccinex price fluctuation can be explain by its past prices.
Correlation Coefficient
0.26
Spearman Rank Test
-0.19
Residual Average
0.0
Price Variance
0.02
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.